Bharat Biotech & ICMR to launch indigenous COVID vaccine by August 15
ICMR expects to launch the COVID vaccine by August 15 after the completion of the clinical trials. To step up these efforts, ICMR has written to all stockholders to treat it as top priority.
ICMR has developed the indigenous COVID-19 vaccine (BBV152 COVID vaccine) partnered with BBIL. The ICMR has selected 12 institutes for clinical trial of the country's first indigenous Covid-19 vaccine, an official had said on Thursday.
The 12 institutes have been asked by the ICMR to fast track clinical trials of the vaccine as it is being considered as one of the top priority projects which are being monitored at the topmost level of the government.
BBIL is working expeditiously to meet the target, however, the final outcome will depend on the cooperation of all clinical trial sites involved in this project, the ICMR told the selected institutes.
Hyderabad-based Bharat Biotech successfully developed Covaxin in collaboration with the ICMR and National Institute of Virology (NIV). The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech.
By IGNITED MINDS
Comments
Post a Comment